Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.7K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.7K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

13.0K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.0K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

42
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
42
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

5.9K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic β-cell aging in physiology and diabetes: emerging roles of m6A mRNA methylation.

Journal of molecular endocrinology·2026
Same author

Long QT syndrome and hypoglycemia in a postbariatric surgery patient with a likely pathogenic variant in <i>KCNE1</i>.

JCEM case reports·2026
Same author

Insulin/IGF signaling in islet biology and its therapeutic implications.

Endocrine reviews·2026
Same author

Proteomic analyses of human islets reveal potential markers of β cell dysfunction during prediabetes.

JCI insight·2026
Same author

Single-Islet Proteomics Maps Pseudo-Temporal Islet Immune Responses and Dysfunction in Stage 1 Type 1 Diabetes.

bioRxiv : the preprint server for biology·2025
Same author

Exploring Size Exclusion Chromatography Columns 20 and 35 nm Pore Size Effect for Isolation of Extracellular Vesicles.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 23, 2026

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
09:31

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

13.4K

Epigenetic modifiers of islet function and mass.

Dario F De Jesus1, Rohit N Kulkarni2

  • 1Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA; Graduate Program in Areas of Basic and Applied Biology (GABBA), Abdel Salazar Biomedical Sciences Institute, University of Porto, 5000 Porto, Portugal.

Trends in Endocrinology and Metabolism: TEM
|September 24, 2014
PubMed
Summary
This summary is machine-generated.

Aging impacts type 2 diabetes (T2D) risk through epigenetic changes in pancreatic beta cells. Understanding these aging-related epigenetic mechanisms is key for developing new diabetes prevention therapies.

More Related Videos

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
11:24

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

5.1K
Sustained Administration of &#946;-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

5.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
09:31

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

13.4K
Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
11:24

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

5.1K
Sustained Administration of &#946;-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

5.9K

Area of Science:

  • Endocrinology
  • Gerontology
  • Molecular Biology

Background:

  • Type 2 diabetes (T2D) involves insulin resistance and pancreatic beta-cell dysfunction.
  • Aging is a significant risk factor for T2D, with underlying mechanisms involving epigenetics.
  • Epigenetic modifications influence gene expression in response to environmental factors and aging.

Purpose of the Study:

  • To review the effects of aging on pancreatic beta-cell function and adaptation.
  • To explore the role of mitochondria in islet bioenergetics and the epigenome.
  • To identify key modulators of the islet epigenome during aging.

Main Methods:

  • Literature review focusing on aging, epigenetics, and pancreatic beta-cell function.
  • Analysis of signaling pathways regulating the islet epigenome.
  • Discussion of mitochondrial roles in islet bioenergetics.

Main Results:

  • Aging impairs beta-cell function and adaptation, contributing to T2D susceptibility.
  • Mitochondria play a critical role in islet bioenergetics and the regulation of the epigenome.
  • Metabolites, hormones, and nutritional status are key modulators of the islet epigenome during aging.

Conclusions:

  • Understanding aging-related epigenetic changes in beta cells is crucial for T2D pathogenesis.
  • Targeting epigenetic pathways may offer novel therapeutic strategies for diabetes prevention.
  • Further research into signaling pathways can elucidate disease progression and inform treatment development.